naltrexone prodrug

Naltrexone prodrug is a small molecule therapeutic developed by Rusan Healthcare, specifically designed for the treatment of opioid and alcohol dependence. It serves as a precursor to naltrexone, a potent opioid receptor antagonist. By blocking mu-opioid receptors, the drug inhibits the reinforcing effects of opioids and reduces alcohol cravings, facilitating long-term abstinence. This prodrug formulation is typically engineered for long-term release, often as a depot injection, to overcome the compliance challenges associated with daily oral naltrexone therapy. It is currently approved for use in managing substance use disorders in specific jurisdictions.

Other names

naltrexone long-acting injectablenaltrexone depot